
Tirzepatide
Dual incretin receptor agonist. Presented as a catalogue material for controlled laboratory research workflows.
For laboratory orientation, tirzepatide is useful as a reference point for research into multi-receptor incretin signalling and biased agonism.
Tirzepatide: compound context & catalogue record.
Compound-level literature, catalogue specifications and availability are deliberately separated so scientific context is not confused with product validation.
Dual incretin receptor agonist
A synthetic peptide investigated for combined agonism at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
Clinical literature
Peer-reviewed receptor-signalling work and large randomized clinical programmes have characterised the pharmacology of the tirzepatide molecule. The scientific literature cited here describes the compound; it does not establish the identity, purity, safety or suitability of a catalogue item.
For laboratory orientation, tirzepatide is useful as a reference point for research into multi-receptor incretin signalling and biased agonism.



